Search Results

Filter
  • 1-10 of  408 results for ""Respiratory Syncytial Virus Infections""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Systematic Review of the Efficacy and Safety of RSV-Specific Monoclonal Antibodies and Antivirals in Development.

  • Authors : Sevendal ATK; Virology Research Laboratory, Serology and Virology Division (SAViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, Australia.; Hurley S

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/administration & dosage ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/adverse effects ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/immunology

  • Source: Reviews in medical virology [Rev Med Virol] 2024 Sep; Vol. 34 (5), pp. e2576.Publisher: Wiley Country of Publication: England NLM ID: 9112448 Publication Model: Print Cited Medium: Internet ISSN: 1099-1654 (Electronic)

Record details

×
Academic Journal

Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina.

  • Authors : Guiñazú G; Centro INFANT de Medicina Traslacional (CIMET), Escuela de Bio y Nanotecnología (EByN), Universidad Nacional de San Martín (UNSAM), Buenos Aires, Argentina.; Dvorkin J

Subjects: Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/prevention & control ; Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/economics ; Cost-Benefit Analysis*

  • Source: Vaccine [Vaccine] 2024 Oct 03; Vol. 42 (23), pp. 126234. Date of Electronic Publication: 2024 Aug 17.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Inhaled "Muco-Trapping" Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections.

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use ; Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/drug therapy; Humans

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Mar; Vol. 11 (12), pp. e2306729. Date of Electronic Publication: 2024 Jan 15.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

×
Academic Journal

FDA Approves RSV Monoclonal Antibody for Infants and Young Children.

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Drug Approval*

  • Source: JAMA [JAMA] 2023 Aug 15; Vol. 330 (7), pp. 586.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants.

  • Authors : Stiboy E; School of Public Health, The University of Sydney, Camperdown, Australia.; Chan M

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use ; Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/prevention & control ; Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/drug therapy

  • Source: Pediatric pulmonology [Pediatr Pulmonol] 2023 Apr; Vol. 58 (4), pp. 1210-1220. Date of Electronic Publication: 2023 Feb 14.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8510590 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Immunization, not vaccination: monoclonal antibodies for infant RSV prevention and the US vaccines for children program.

  • Authors : Sevilla JP; Data for Decisions, LLC, Waltham, MA, USA.

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use ; Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/prevention & control; Infant

  • Source: Journal of medical economics [J Med Econ] 2023 Jan-Dec; Vol. 26 (1), pp. 991-997.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print Cited Medium: Internet ISSN: 1941-837X

Record details

×
Academic Journal

RSV: UK to examine whether to offer monoclonal antibody routinely to all babies.

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use ; Respiratory Syncytial Virus Infections*; Infant

  • Source: BMJ (Clinical research ed.) [BMJ] 2022 Nov 11; Vol. 379, pp. o2725. Date of Electronic Publication: 2022 Nov 11.Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

New preventive strategies for respiratory syncytial virus infection in children.

  • Authors : Glowinski R; Center for Vaccines & Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital and The Ohio State University, Columbus, OH, USA.; Mejias A

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*immunology ; Respiratory Syncytial Virus Infections/Respiratory Syncytial Virus Infections/Respiratory Syncytial Virus Infections/*prevention & control ; Respiratory Syncytial Virus Vaccines/Respiratory Syncytial Virus Vaccines/Respiratory Syncytial Virus Vaccines/*immunology

  • Source: Current opinion in virology [Curr Opin Virol] 2021 Dec; Vol. 51, pp. 216-223. Date of Electronic Publication: 2021 Nov 12.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101560941 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Development and comparison of three cell-based potency assays for anti-respiratory syncytial virus monoclonal antibody.

  • Authors : Sun D; Analytical Research & Development (AR&D), MRL, Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: .; Hsu A

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/pharmacology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/pharmacology ; Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/drug therapy

  • Source: Biologicals : journal of the International Association of Biological Standardization [Biologicals] 2021 Nov; Vol. 74, pp. 1-9. Date of Electronic Publication: 2021 Oct 27.Publisher: Academic Press Country of Publication: England NLM ID: 9004494 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  408 results for ""Respiratory Syncytial Virus Infections""